Elon Musk Agrees to $1.5 Million Settlement with SEC Over Twitter Stake Disclosure
Elon Musk settles with the SEC for $1.5 million after years-long dispute over his Twitter investment
Engadget
Image: Engadget
Elon Musk has settled with the U.S. Securities and Exchange Commission (SEC) for $1.5 million after a prolonged dispute regarding his late disclosure of a significant stake in Twitter. The settlement, which Musk does not admit wrongdoing, could conclude the SEC's investigation into his $44 billion acquisition of the social media platform.
- 01Elon Musk settled with the SEC for $1.5 million over late disclosure of Twitter stake.
- 02The SEC claimed Musk's delay saved him over $150 million at the expense of shareholders.
- 03This penalty is the largest in SEC history for such a violation.
- 04Musk accused the SEC of harassment during the investigation.
- 05The settlement awaits court approval to finalize the dispute.
Advertisement
In-Article Ad
Elon Musk has reached a settlement with the U.S. Securities and Exchange Commission (SEC), agreeing to pay $1.5 million following a dispute over his late disclosure of acquiring a significant stake in Twitter. The SEC initiated an investigation after Musk delayed announcing that he had purchased more than 5 percent of Twitter, which the agency argued saved him over $150 million at the expense of shareholders. Musk has denied any wrongdoing and characterized the SEC's actions as harassment, particularly targeting former SEC chair Gary Gensler. This settlement, pending court approval, marks the end of a lengthy legal battle regarding Musk's $44 billion acquisition of Twitter in 2022. According to reports, the penalty is the largest the SEC has imposed for this type of violation.
Advertisement
In-Article Ad
Advertisement
In-Article Ad
Reader Poll
Do you think the SEC's penalties for late disclosures are effective?
Connecting to poll...
More about Securities and Exchange Commission

Raj Khanna, director de Extreme Networks, vende acciones por $222,000
Investing • May 5, 2026

Barclays propose un passage au reporting semestriel pour alléger la pression sur les entreprises alimentaires
Investing French • May 4, 2026

Hemab Therapeutics annonce le prix de son introduction en bourse à 18$ par action
Investing French • May 1, 2026
Read the original article
Visit the source for the complete story.